Rachel Doherty

721 total citations
21 papers, 577 citations indexed

About

Rachel Doherty is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Rachel Doherty has authored 21 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Ophthalmology. Recurrent topics in Rachel Doherty's work include DNA Repair Mechanisms (9 papers), Ocular Oncology and Treatments (6 papers) and CRISPR and Genetic Engineering (4 papers). Rachel Doherty is often cited by papers focused on DNA Repair Mechanisms (9 papers), Ocular Oncology and Treatments (6 papers) and CRISPR and Genetic Engineering (4 papers). Rachel Doherty collaborates with scholars based in United Kingdom, United States and Switzerland. Rachel Doherty's co-authors include Srinivasan Madhusudan, Karen Sisley, Andrew R. Green, Paul M. Moseley, Christina J. Perry, Arvind Arora, Stephen Chan, Ian O. Ellis, Emad A. Rakha and Graham Ball and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Ophthalmology.

In The Last Decade

Rachel Doherty

21 papers receiving 567 citations

Peers

Rachel Doherty

ONCOL

PRM

Е. В. Степанова Russia

Grazia Carbotti Italy

Xiumei Zhao China

Shinji Takagi Japan

Yanfang Huang China

Honghe Wang United States

Shuzhen Tan China

Florent Poyer France

Jeremiah L. Oyer United States

Dimple Modi United States

Е. В. Степанова Russia

Rachel Doherty

506 ×1.4

165 ×0.7

ONCOL

175 ×1.4

137 ×2.2

PRM

65 ×1.1

Citations per year, relative to Rachel Doherty Rachel Doherty (= 1×) peers Е. В. Степанова

Countries citing papers authored by Rachel Doherty

Since Specialization

Citations

This map shows the geographic impact of Rachel Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Doherty more than expected).

Fields of papers citing papers by Rachel Doherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Doherty. The network helps show where Rachel Doherty may publish in the future.

Co-authorship network of co-authors of Rachel Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Doherty. A scholar is included among the top collaborators of Rachel Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Doherty. Rachel Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mesquita, Katia A., Reem Ali, Rachel Doherty, et al.. (2021). FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers. Cancers. 13(8). 1866–1866. 19 indexed citations

Doherty, Rachel, Helen E. Bryant, Manoj K. Valluru, I G Rennie, & Karen Sisley. (2019). Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma. Cancers. 11(9). 1278–1278. 14 indexed citations

Mudhar, Hardeep Singh, Rachel Doherty, Sachin M. Salvi, et al.. (2018). Genetic Profiling of Primary Orbital Melanoma. Ophthalmology. 126(7). 1045–1052. 6 indexed citations

Marks, Michael, Rachel Doherty, Sally-Ann Ohene, et al.. (2017). Knowledge, attitudes and practices towards yaws and yaws-like skin disease in Ghana. PLoS neglected tropical diseases. 11(7). e0005820–e0005820. 10 indexed citations

Fabian, Ido Didi, Caroline Thaung, Karen Sisley, et al.. (2017). Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma. American Journal of Ophthalmology. 181. 97–105. 6 indexed citations

Doherty, Rachel, Karen Sisley, David W. Hammond, I G Rennie, & Neil A. Cross. (2017). Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics. Investigative Ophthalmology & Visual Science. 58(12). 5387–5387. 13 indexed citations

Wright, David M., Michael Rosato, Rachel Doherty, & Dermot O’Reilly. (2016). Teenage motherhood: where you live is also important. A prospective cohort study of 14,000 women. Health & Place. 42. 79–86. 8 indexed citations

Doherty, Rachel, Igor V. Sazanovich, Luke K. McKenzie, et al.. (2016). Photodynamic killing of cancer cells by a Platinum(II) complex with cyclometallating ligand. Scientific Reports. 6(1). 22668–22668. 91 indexed citations

Robertson, Emily, Christina J. Perry, Rachel Doherty, & Srinivasan Madhusudan. (2016). Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.. PubMed. 12(3). 103–12. 30 indexed citations

10.

Arora, Arvind, Tarek M. Abdel-Fatah, Devika Agarwal, et al.. (2015). Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics. 14(4). 1057–1065. 42 indexed citations

11.

Alsubhi, Nouf H., Fiona K. Middleton, Tarek M.A. Abdel-Fatah, et al.. (2015). Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer. Molecular Oncology. 10(2). 213–223. 30 indexed citations

12.

Doherty, Rachel & Srinivasan Madhusudan. (2015). DNA Repair Endonucleases: Physiological Roles and Potential as Drug Targets. SLAS DISCOVERY. 20(7). 829–841. 17 indexed citations

13.

Arora, Arvind, Tarek M. Abdel-Fatah, Devika Agarwal, et al.. (2015). Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis. 37(1). 63–71. 31 indexed citations

14.

Abdel-Fatah, Tarek M., Arvind Arora, Nouf H. Alsubhi, et al.. (2014). Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts. Neoplasia. 16(11). 982–991. 36 indexed citations

15.

Abdel-Fatah, Tarek M.A., Christina J. Perry, Arvind Arora, et al.. (2014). Is There a Role for Base Excision Repair in Estrogen/Estrogen Receptor-Driven Breast Cancers?. Antioxidants and Redox Signaling. 21(16). 2262–2268. 25 indexed citations

16.

Abdel-Fatah, Tarek M.A., Fiona K. Middleton, Arvind Arora, et al.. (2014). Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology. 9(3). 569–585. 71 indexed citations

17.

Albarakati, Nada, Tarek M.A. Abdel-Fatah, Rachel Doherty, et al.. (2014). Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology. 9(1). 204–217. 65 indexed citations

18.

Mudhar, Hardeep Singh, Rachel Doherty, Abdulazeez Salawu, Karen Sisley, & I G Rennie. (2013). Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somaticGNAQmutations. British Journal of Ophthalmology. 97(7). 924–928. 10 indexed citations

19.

Doherty, Rachel, Sarah Haywood‐Small, Karen Sisley, & Neil A. Cross. (2011). Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells. Biochemical and Biophysical Research Communications. 414(4). 801–807. 30 indexed citations

20.

Sisley, Karen, Rachel Doherty, & Neil A. Cross. (2011). What hope for the future? GNAQ and uveal melanoma. British Journal of Ophthalmology. 95(5). 620–623. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact